Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol as Adjunct to Methotrexate in Rheumatoid Arthritis
NCT05594680Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Oct 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in rheumatoid arthritis (RA), sponsored by Tanta University. Started Oct 2022; status: recruiting.
02
Drugs
cilostazol
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05594680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05594680.